ライフサイエンスコーパス: task force

1 verweight, or obesity (International Obesity Task Force).

2 ittee on Resuscitation Neonatal Life Support Task Force.

3 ars and older for the US Preventive Services Task Force.

4 adults to inform the US Preventive Services Task Force.

5 escents to inform the US Preventive Services Task Force.

6 auma have been developed by a multispecialty task force.

7 sk assessment for the US Preventive Services Task Force.

8 of OSA, to inform the US Preventive Services Task Force.

9 factors to inform the US Preventive Services Task Force.

10 5 years to inform the US Preventive Services Task Force.

11 of CVD to inform the US Preventive Services Task Force.

12 and Prevention Community Preventive Services Task Force.

13 ever performed by the Pediatric Life Support Task Force.

14 ociety of Intensive Care Medicine convened a task force (19 participants) to revise current sepsis/se

15 ollege of Allergy, Asthma & Immunology Joint Task Force 2012 AD Practice Parameter and the 2014 Ameri

16 thers, p = 0.54) or U.S. Preventive Services Task Force (43.7% vs. 43.7%, p = 0.99) or higher rates o

17 The Task Force achieved a comprehensive position in defining

18 y 69% to achieve the Gulf of Mexico Nutrient Task Force Action Plan target hypoxic area of 5000 km(2)

19 The task force also recognises the scarcity of quality infor

20 The task forces also listed priority knowledge gaps for furt

21 f Physicians (ACP), U.S. Preventive Services Task Force, American Academy of Family Physicians, Ameri

22 llergy and Clinical Immunology have formed a task force and developed a drug allergy passport as well

23 terature with viewpoints from members of the task force and invited experts to provide a global overv

24 rican College of Physicians' High Value Care Task Force and the Centers for Disease Control and Preve

25 ndations were approved by all members of the task force and then assembled into a complete document.

26 itation and Chronic Care Group established a Task Force and writing committee to develop a policy sta

27 n statement was prepared by subgroups of the task force, and then the material from the various secti

28 ns, the Education, Implementation, and Teams Task Force applied the population, intervention, compara

29 ment was developed by an international joint task force, appointed by the American Thoracic Society a

30 Insights into the deliberations of the task forces are provided in the Justification and Eviden

31 The task force assessed the design, user engagement, content

32 A multidisciplinary task force at a pediatric hospital developed an evidence

33 The guidelines delineated creation of a task force at each university; school-based risk screeni

34 The Task Force based the recommendation primarily on the res

35 The EAACI task force behind this position paper has therefore comb

36 espite these limitations, the members of the Task Force believe that these recommendations provide a

37 The Task Force chairs reviewed and organized primary literat

38 The Task Force commissioned an evidence review that assessed

39 mic SVD was determined according to European task force committee guidelines.

40 In September 2013, a multidisciplinary task force, composed of pediatric practitioners from ter

41 Delphi process; (2) a Delphi study among the task force comprising 3 surveys and discussions of resul

42 The Task Force concluded that postmenopausal women with an e

43 The task force concluded the term severe sepsis was redundan

44 cent reports from the US Preventive Services Task Force concluding that there was insufficient eviden

45 and management guidelines are based on that task force consensus and should continue to evolve as cl

46 Liaison Committee on Resuscitation First Aid Task Force Consensus on Science With Treatment Recommend

47 The 18-member task force consisted of experts including pulmonologists

48 A project task force, consisting of the committee as a whole, was

49 A task force convened by the National Cancer Grid of India

50 t, Development, and Evaluation expert on the Task Force created profiles for the evidence related to

51 es, including those already used by modified Task Force Criteria (mTFC), and others such as strain im

52 is (n=31) were older (P=0.005) and met fewer Task Force Criteria (P=0.013) than those who developed H

53 esonance (CMR) is a component of the revised Task Force Criteria (rTFC) for the diagnosis of arrhythm

54 med to determine cardiac MR imaging-specific Task Force Criteria (TFC) and non-TFC features (ARVD/C-t

55 ricular cardiomyopathy probands who met 2010 Task Force Criteria and had undergone genotyping that in

56 A definite/borderline 2010 International Task Force Criteria arrhythmogenic right ventricular car

57 gnostic value of fat quantification by using task force criteria as a reference.

58 C was not included in the 2010 International Task Force Criteria for arrhythmogenic right ventricular

59 We examined 62 consecutive patients with Task Force criteria for arrhythmogenic right ventricular

60 Although the Task Force Criteria for arrhythmogenic right ventricular

61 bers with mutations were more likely to meet Task Force Criteria for ARVD/C (40% versus 18%), experie

62 cement complying with the 2010 International Task Force Criteria in the LV.

63 An amendment to the current International Task Force Criteria is reasonable to better diagnose pat

64 Current Task Force criteria may fail to diagnose biventricular A

65 t (LD), or biventricular subtypes using 2010 Task Force Criteria or proposed features of LD disease,

66 ite, borderline, possible) based on the 2010 Task Force Criteria was reclassified after genetic readj

67 The Movement Disorder Society Task Force criteria were used to classify the Parkinson'

68 adjudicated for 289 patients meeting ARVC/D Task Force Criteria.

69 LV involvement related to none of the Task Force criteria.

70 lated cardiomyopathy fulfilled definite 2010 Task Force criteria.

71 based on the presence of 2010 International Task Force criteria: 1) subclinical stage (n = 21); 2) e

72 specific BMI z-score > International Obesity Task Force cut-off and WC z-score > 90th percentile, res

73 sity defined using the International Obesity Task Force cut-points, and change in health status (DALY

74 he Third International Consensus Definitions Task Force defined sepsis as "life-threatening organ dys

75 This document summarizes the task force deliberations and follow-up discussions, and

76 oderate) DED patients based on International Task Force Delphi Panel severity grading, and controls,

77 The Task Force developed 10 weak recommendations.

78 The Task Force developed 18 strong and five weak recommendat

79 The Task Force developed a single strong recommendation: we

80 ient but expert consensus was unanimous, the Task Force developed six good practice statements.

81 s of 85 patients with ARVD/C fulfilling 2010 Task Force diagnostic criteria (TFC) from a transatlanti

82 e topics that resulted in the most extensive task force discussions included CPR during transport, CP

83 ade because of the scarcity of evidence, the task force either used evidence from studies of patients

84 Preventive Services Task Force endorsed aspirin for primary prevention of ca

85 The task force endorsed the "Be He@lthy, Be Mobile" WHO init

86 The 'Allergy and Asthma Severity' EAACI Task Force examined the current evidence and produced th

87 This white paper summarizes the task force findings and makes recommendations for future

88 This paper is the compilation of a task force focussed on practical aspects of this techniq

89 defects to inform the US Preventive Services Task Force for an updated Recommendation Statement.

90 scents to support the US Preventive Services Task Force for an updated recommendation statement.

91 g from the United States Preventive Services Task Force for population-based skin cancer screening.

92 At IWWM-8, a task force for treatment recommendations was impanelled

93 eutics (ASRS ReST) Committee, an independent task force formed to monitor device-related and drug-rel

94 The Community Preventive Services Task Force found sufficient evidence of effectiveness to

95 reiterations of existing statements when the task force found they remained valid.

96 The Neonatal Life Support Task Force generally determined by consensus the type of

97 iology Foundation/American Heart Association Task Force Guideline for the Diagnosis and Treatment of

98 ervals recommended by the 2008 Multi-Society Task Force guidelines.

99 The Task Force has asked modelers to reassess the loading re

100 The First Aid Task Force has assessed, discussed, and debated the cert

101 The US Multi-Society Task Force has developed updated recommendations to guid

102 Although the task force has the final responsibility for the content

103 and Prevention and U.S. Preventive Services Task Force have highlighted public screening as an essen

104 rnational Liaison Committee on Resuscitation task forces have assessed, discussed, and debated the ce

105 Two subsequent IDSA task forces have emphasized the importance of women, and

106 tematic review by the US Preventive Services Task Force in the noncancer population was used as the e

107 ntions to support the US Preventive Services Task Force in updating its 2008 recommendation.

108 rning paradigms; and 3) the establishment of task forces in emerging areas of multimodality imaging a

109 The task force included recommendation statements in the fin

110 The task force included two representatives from national pa

111 diological Society of North America COVID-19 Task Force, including discussions with colleagues and le

112 For this task force initiative of the European Academy of Allergy

113 Therefore, this Task Force initiative of the European Academy of Allergy

114 To address this unmet need, an international task force involving experts from different organization

115 h those defined by the International Obesity Task Force (IOTF), which used cross-sectional data, and

116 ual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI o

117 November 2013, the U.S. Preventive Services Task Force issued a guideline on medications for risk re

118 In May 2015, the U.S. Preventive Services Task Force issued a guideline on screening for thyroid d

119 f aspirin in primary disease prevention, the Task Force issued a guideline titled, "Aspirin Use for t

120 ctions was aggregated, and the leader of the task force (J.D.S.) merged the material into a cohesive

121 The Task Force, led by Richard L.

122 classified using Movement Disorders Society Task Force level I (Montreal Cognitive Assessment <26) a

123 cal or optimal clinical practice varies, the Task Force made no recommendations for nine of the topic

124 e otherwise optimal therapy.Conclusions: The task force made recommendations regarding the pharmacolo

125 The task force makes 10 CRC screening recommendations that e

126 uthor's name in the AJCC Ophthalmic Oncology Task Force Member Authors section in the Article Informa

127 rnational Liaison Committee on Resuscitation task force members are provided in Values and Preference

128 Task force members conducted additional independent sear

129 Finally, the task force members have prioritized and listed the top 3

130 or future data collection and reporting, the task force members propose relevant definitions and impo

131 Task Force members reviewed this material and all availa

132 Task force members were charged with comprehensively cat

133 The experience and expertise of task force members were used to develop recommended best

134 equired the agreement of at least 80% of the task force members.

135 A task force (n = 19) with expertise in sepsis pathobiolog

136 etic Trainers' Association Inter-Association Task Force (NATA-IATF) released guidelines to reduce exe

137 y in the middle of the International Obesity Task Force normal weight range, but during adulthood, th

138 4; 95% CI, 1.15-6.06), International Obesity Task Force obesity cutoffs (OR, 2.38; 95% CI, 1.06-5.34)

139 A multispecialty task force of 16 international experts in critical care

140 ng recommendations of the U.S. Multi-Society Task Force of Colorectal Cancer (MSTF), which represents

141 Through these evidence-based guidelines, a task force of EANO provides recommendations for the diag

142 We established a task force of experts from a multicountry (the USA, Euro

143 laucoma subspecialists, convened a 12-member task force of experts to craft a position statement abou

144 A multi-specialty task force of international experts in critical care med

145 Inclusion in Trauma Surgery Practice Ad Hoc Task Force of the Eastern Association for the Surgery of

146 The current survey, which was conducted by a task force of the European Academy of Allergy and Clinic

147 The multidisciplinary palliative care task force of the European Association of Neuro-Oncology

148 The meningioma task force of the European Association of Neuro-Oncology

149 s article, the recently established COVID-19 Task Force of the German Society for Clinical Chemistry

150 A Task Force of the Immunotherapy and Aerobiology and Poll

151 iews performed by the Pediatric Life Support Task Force of the International Liaison Committee on Res

152 cy cardiovascular care follows the Pediatric Task Force of the International Liaison Committee on Res

153 t were prioritized by the Basic Life Support Task Force of the International Liaison Committee on Res

154 es identified were analyzed by the Pediatric Task Force of the International Liaison Committee on Res

155 area of research, the Colon and Rectal-Anal Task Forces of the United States National Cancer Institu

156 EAACI Task Force on 'Contraindications to AIT' was created to

157 astroenterological Association and the Joint Task Force on Allergy Immunology Practice Parameters.

158 ological Association Institute and the Joint Task Force on Allergy-Immunology Practice Parameters to

159 ean Academy of Allergy & Clinical Immunology Task Force on Anti-infectives in Asthma was initiated to

160 The Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR) in 2015

161 In a previous publication, the Transatlantic Task Force on Antimicrobial Resistance (TATFAR) summariz

162 onal guidelines created by the 2012 European Task Force on Atopic Dermatitis and the 2013 Asia-Pacifi

163 ean Academy of Allergy & Clinical Immunology Task Force on Biomarkers in Asthma was initiated to revi

164 The US Multi-Society Task Force on Colorectal Cancer, with invited experts, d

165 n Academy of Allergy and Clinical Immunology Task Force on Diet and Immunomodulation has systematical

166 In 1993, the International Task Force on Disease Eradication classified the politic

167 ing the US Institute of Medicine, the Global Task Force on Expanded Access to Cancer Care and Control

168 e American College of Critical Care Medicine Task Force on Models of Critical Care: 1) An intensivist

169 n Academy of Ophthalmology (AAO) created the Task Force on Myopia in recognition of the substantial g

170 idelines from the American Heart Association Task Force on Practice Guidelines.

171 ompared with those created by the 2012 Joint Task Force on Practice Parameters representing the Ameri

172 Description: The Joint Task Force on Practice Parameters, which comprises repre

173 A European Respiratory Society Task Force on Pulmonary-Hepatic Disorders convened in 20

174 We applied the Global Task Force on Radiotherapy for Cancer Control investment

175 matic review by the U.S. Preventive Services Task Force on screening and supplementation for IDA in p

176 date evidence for the US Preventive Services Task Force on the benefits and harms of hormone therapy

177 DeCaprio A, Carpenter DO, and the Akwesasne Task Force on the Environment.

178 nt conclusions of the US Preventive Services Task Force on the need for further data that address exi

179 sk of obesity based on International Obesity Task Force or World Health Organization body mass index

180 US Preventive Services Task Force, Owens DK, Davidson KW, et al.

181 In this task force paper of the Interest Group on Biologicals of

182 ittee on Resuscitation Advanced Life Support Task Force performed a systematic review to evaluate 3 k

183 In 2019, the U.S. Preventive Services Task Force performed an evidence review and updated its

184 In this EAACI task force position paper, we provide an overview of the

185 scoping reviews and the evidence update, the task force prioritized several topics for new systematic

186 n October 2015, the U.S. Preventive Services Task Force published recommendations on screening for ab

187 y quality using the U.S. Preventive Services Task Force quality rating criteria.

188 w to support the 2019 US Preventive Services Task Force Reaffirmation Recommendation Statement on ocu

189 An intergovernmental Task Force recently extended to 2035 the deadline for ac

190 The US Preventive Services Task Force recently recommended the use of aspirin to pr

191 An international task force recently redefined the concept of sepsis.

192 ol and Prevention and US Preventive Services Task Force recommend one-time hepatitis C virus (HCV) te

193 lementing this Community Preventive Services Task Force recommendation in communities across the Unit

194 Community Preventive Services Task Force recommendation on the use of combined diet an

195 w to support the 2019 US Preventive Services Task Force Recommendation Statement on screening for hep

196 r unhealthy drug use: US Preventive Services Task Force recommendation statement.

197 olescents and adults: US Preventive Services Task Force Recommendation Statement.

198 ment in older adults: US Preventive Services Task Force recommendation statement.

199 a radiologist discuss the application of the Task Force recommendation to an individual patient.

200 holesterol and 2016 U.S. Preventive Services Task Force recommendations for statin use in primary pre

201 guidelines and 2016 U.S. Preventive Services Task Force recommendations, respectively.

202 More recently, the U.S. Preventive Services Task Force recommended "initiating low-dose aspirin use

203 ations: Recently, the US Preventive Services Task Force recommended any of 8 CRC screening approaches

204 Preventive Services Task Force recommended biennial mammography screening fo

205 December 2013, the U.S. Preventive Services Task Force recommended screening for lung cancer with lo

206 This task force recommended the use of the quick Sequential O

207 The task force recommends against prehospital cooling with r

208 The US Preventive Services Task Force recommends against screening for thyroid canc

209 The Task Force recommends glucose screening every 3 years fo

210 The United States Preventive Services Task Force recommends lung cancer screening with low-dos

211 The task force recommends targeted temperature management fo

212 The Critical Care Choosing Wisely Task Force recommends that intensivists offer patients a

213 The Task Force recommends the use of combined diet and physi

214 In 2016, the Community Preventive Services Task Force released a recommendation for built environme

215 To update the 2008 U.S. Preventive Services Task Force review on dyslipidemia screening in younger a

216 Preventive Services Task Force review on the benefits and harms of screening

217 ns not covered in the US Preventive Services Task Force review were also included.

218 A multidisciplinary, international task force reviewed AMR cases in the context of four fac

219 dback on the draft document, which the Joint Task Force reviewed before finalizing the guideline.

220 search was performed and all members of the Task Force reviewed relevant references, summarizing hig

221 Preventive Services Task Force reviewed the benefits and harms of ECG screen

222 The parameter was then evaluated by Joint Task Force reviewers and then by reviewers assigned by t

223 isk [RR], 0.80 [95% CI, 0.73-0.89]; Canadian Task Force: RR, 0.82 [95% CI, 0.74-0.94]; Cochrane: RR,

224 d eradication as "none." Here we revisit the Task Force's assessment in light of developments in typh

225 This presidential advisory summarizes the task force's main considerations in determining the 2030

226 published evidence reviewed by the First Aid Task Force science experts.

227 rnational Liaison Committee on Resuscitation Task Force science experts.

228 igo Area Scoring Index and Vitiligo European Task Force scoring system.

229 he Third International Consensus Definitions Task Force (Sepsis-3) recently recommended changes to th

230 ciplinary field of AllergoOncology was given Task Force status by the European Academy of Allergy and

231 The task force suggests ways to ease the entry for new resea

232 A task force supported by the American Thoracic Society, C

233 The United States Preventive Services Task Force supports individualised decision-making for p

234 In a recent EAACI task force survey, the current practice of allergy diagn

235 In conjunction with the Joint Task Force, the workgroup reviewed the evidence and deve

236 tic Association convened a multidisciplinary task force to address cardiovascular concerns in collegi

237 of Allergy and Clinical Immunology created a task force to assess the state of the art and future pot

238 of Retina Specialists (ASRS) formed a joint task force to define clinical characteristics of HORV an

239 e CF Foundation convened a multi-stakeholder task force to develop CRC screening recommendations.

240 f Neuro-Oncology created a multidisciplinary task force to establish evidence-based guidelines for im

241 ergy and Clinical Immunology has organized a task force to provide data and recommendations regarding

242 he European Atherosclerosis Society formed a task force to provide practical clinical guidance focusi

243 American Society for Cell Biology convened a task force to report on the potential, challenges, and l

244 n College of Emergency Physicians convened a Task Force to understand the implications of emergency d

245 pport collaboration among key committees and task forces to identify and implement pro-inclusion and

246 RATIONALE: The Sepsis-3 Task Force updated the clinical criteria for sepsis, exc

247 The task force used Grading of Recommendations Assessment, D

248 relative accuracy of US Preventive Services Task Force (USPSTF) and American College of Cardiology/A

249 In November 2009, the US Preventive Services Task Force (USPSTF) changed its mammography recommendati

250 The U.S. Preventive Services Task Force (USPSTF) develops evidence-based recommendati

251 In 2012, the US Preventive Services Task Force (USPSTF) discouraged prostate-specific antige

252 ommendations from the US Preventive Services Task Force (USPSTF) emphasize therapy based on the prese

253 ing criteria of the U.S. Preventive Services Task Force (USPSTF) for annual CT lung screening were an

254 A 2012 review for the US Preventive Services Task Force (USPSTF) found antiretroviral therapy (ART) a

255 A 2014 review for the US Preventive Services Task Force (USPSTF) found antiviral therapy for hepatiti

256 0 to 69 years), and U.S. Preventive Services Task Force (USPSTF) guidelines (biennial for those aged

257 Preventive Services Task Force (USPSTF) guidelines, it preferentially select

258 The purpose of the U.S. Preventive Services Task Force (USPSTF) is to provide evidence-based recomme

259 The US Preventive Services Task Force (USPSTF) is updating its 2008 colorectal canc

260 The US Preventive Services Task Force (USPSTF) makes recommendations to primary car

261 A 2013 review for the US Preventive Services Task Force (USPSTF) of hepatitis C virus (HCV) screening

262 The US Preventive Services Task Force (USPSTF) previously found strong evidence tha

263 In July 2014, the U.S. Preventive Services Task Force (USPSTF) published a clinical guideline on sc

264 The U.S. Preventive Services Task Force (USPSTF) recently issued guidelines on screen

265 icantly following the US Preventive Services Task Force (USPSTF) recommendation against prostate-spec

266 ed following the 2008 US Preventive Services Task Force (USPSTF) recommendation against prostate-spec

267 To update the 2012 US Preventive Services Task Force (USPSTF) recommendation on behavioral counsel

268 To update the 2009 US Preventive Services Task Force (USPSTF) recommendation on folic acid supplem

269 e: To update the 2008 US Preventive Services Task Force (USPSTF) recommendation on primary care inter

270 To update the 2011 US Preventive Services Task Force (USPSTF) recommendation on screening for ambl

271 To issue a new US Preventive Services Task Force (USPSTF) recommendation on screening for celi

272 Update of the 2009 US Preventive Services Task Force (USPSTF) recommendation on screening for depr

273 e: To update the 2005 US Preventive Services Task Force (USPSTF) recommendation on screening for geni

274 To issue a new US Preventive Services Task Force (USPSTF) recommendation on screening for gyne

275 Update of the US Preventive Services Task Force (USPSTF) recommendation on screening for impa

276 e: To update the 2008 US Preventive Services Task Force (USPSTF) recommendation on screening for lipi

277 To update the 2010 US Preventive Services Task Force (USPSTF) recommendation on screening for obes

278 To issue a new US Preventive Services Task Force (USPSTF) recommendation on screening for OSA

279 To update the 1996 US Preventive Services Task Force (USPSTF) recommendation on screening for pree

280 To update the US Preventive Services Task Force (USPSTF) recommendation on screening for thyr

281 To update the 2012 US Preventive Services Task Force (USPSTF) recommendation on the use of menopau

282 e with the United States Preventive Services Task Force (USPSTF) recommendations can reduce morbidity

283 2015, the United States Preventive Services Task Force (USPSTF) recommended targeted screening for p

284 The US Preventive Services Task Force (USPSTF) recommends computed tomography (CT)

285 The US Preventive Services Task Force (USPSTF) recommends lung cancer screening amo

286 Preventive Services Task Force (USPSTF) reviewed evidence on the benefits an

287 Preventive Services Task Force (USPSTF) summarizes the principles and consid

288 Preventive Services Task Force (USPSTF), 77 years according to the Centers f

289 oups, including the U.S. Preventive Services Task Force (USPSTF), recommend a range of clinical preve

290 ic conditions for the US Preventive Services Task Force (USPSTF).

291 A multidisciplinary, expert Task Force was appointed and assembled by the Society of

292 es, a multidisciplinary, multi-institutional task force was convened, incorporating expertise in crit

293 PROviding better Access To Organs (PROACTOR) Task Force was created to inform ongoing ASTS organ acce

294 A Task Force was established, to explore the clinical spec

295 The task force was unable to reach agreement on a single tes

296 e context of this EAACI Lifestyle and asthma Task Force, we summarize the evidence from existing syst

297 Members of the task force were divided into 13 subcommittees, each focu

298 The members of the task force were selected by the AGS Board of Directors a

299 sitivity diagnosis was performed by an EAACI task force, which reviewed and evaluated the literature

300 ginal paper, several members of the original task force with specific expertise provided a more in-de